This study aimed to characterize in vitro dolutegravir (DTG) and bictegravir (BIC) binding. They had a preferential binding to human serum albumin (HSA) with two classes of albumin sites. Human alpha-1-acid glycoprotein (HAAG) binding of DTG and BIC showed an atypical nonlinear binding. The low-affinity site on HSA, the main plasma binding protein, suggests that the high protein binding rate should not impair passive diffusion.
Keywords: bictegravir; dolutegravir; human alpha-1-acid glycoprotein; human serum albumin; pharmacokinetics; protein binding.
Copyright © 2020 American Society for Microbiology.